TELA - TELA Bio, Inc. Trailing Twelve Months Revenue Growth

TELA Bio, Inc. (TELA) is attracting leading biomaterials engineers by providing them with comfortable conditions and research freedom. Production is being modernized through the implementation of AI robots for high-precision fabric cutting. However, high expenses for sales personnel are creating a free cash flow deficit. The year-over-year (TTM) operating revenue trend captures current dynamics, with the parameter stabilizing at 1.40.
TELA Bio Inc. (TELA) - metric breakdowns and financial figures

Business quality during screening is evaluated by the ability to generate a sustainable cash flow. This indicator measures the percentage change in total revenue over the last twelve months relative to the preceding year. For TELA Bio, Inc. (TELA), the stability of this metric is supported by the defensive qualities of surgical devices, which remain in demand regardless of the market cycle. By analyzing the current 12-month revenue dynamics compared to the same period, an investor determines the fundamental viability of the company.